中国药物警戒2024,Vol.21Issue(11) :1312-1314.DOI:10.19803/j.1672-8629.20240280

吲达帕胺片致急性呼吸窘迫综合征1例分析

One Case of Acute Respiratory Distress Syndrome Caused by Indapamide Tablets

骆宇琛 弓清梅 徐钰行 秦树琴 张囝
中国药物警戒2024,Vol.21Issue(11) :1312-1314.DOI:10.19803/j.1672-8629.20240280

吲达帕胺片致急性呼吸窘迫综合征1例分析

One Case of Acute Respiratory Distress Syndrome Caused by Indapamide Tablets

骆宇琛 1弓清梅 1徐钰行 1秦树琴 2张囝3
扫码查看

作者信息

  • 1. 山西医科大学附属山西省人民医院重症医学科,山西 太原 030012
  • 2. 中铁十七局集团有限公司中心医院重症医学科,山西太原 030012
  • 3. 河津市人民医院急诊科,山西河津 043300
  • 折叠

摘要

目的 探讨吲达帕胺引起的罕见并发症,为临床治疗提供指导.方法 分析1例服用吲达帕胺致急性呼吸窘迫综合征(ARDS)的病例,通过国内外文献分析对此不良反应的发病机制、临床表现、治疗等进行讨论.结果 此患者经无创呼吸机辅助通气、抗感染、升压、补液等对症治疗后,氧合改善,胸部CT好转出院.但目前对于吲达帕胺致急性呼吸窘迫综合征的具体机制尚不清楚,未来仍需进一步研究明确其发病机制.结论 吲达帕胺常见的不良反应为低钾血症、低钠血症及电解质失衡等,应警惕吲达帕胺致ARDS的罕见不良反应.

Abstract

Objective To call attention to rare complications caused by indapamide so as to provide references for clinical treatment.Methods One case of acute respiratory distress syndrome(ARDS)attributed to indapamide intake was reported.The pathogenesis,clinical manifestations,and treatment of this adverse reaction were analyzed bases on domestic and foreign literature.Results After symptomatic treatments including non-invasive ventilatory support,anti-infection therapy,vasopressor therapy,and hydration therapy,the patient's oxygenation improved,and the chest CT scan showed favorable progression,leading to discharge.However,the underlying mechanism by which indapamide triggered ARDS had yet to be elucidated,so more research was needed to discern its pathogenesis.Conclusion While hypokalemia,hyponatremia,and electrolyte imbalances are commonly reported adverse reactions of indapamide,it is crucial to be vigilant to the rare but potential risks of ARDS associated with its use.

关键词

急性肺损伤/急性呼吸窘迫综合征/吲达帕胺/过敏反应/不良反应

Key words

Acute Lung Injury/Acute Respiratory Distress Syndrome/Indapamide/Anaphylaxis/Adverse Reaction

引用本文复制引用

出版年

2024
中国药物警戒
国家药品监督管理局药品评价中心(国家药品不良反应监测中心)

中国药物警戒

CSTPCD
影响因子:1.105
ISSN:1672-8629
段落导航相关论文